HL7® Version 3 Standard, © 2012 Health Level Seven International®. All Rights Reserved.
HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. Pat & TM Off.

Reproduction of this material in any form is strictly forbidden without the written permission of the publisher.

Ann Arbor, MI
USA
November 2012

Version 3 Standard: Regulated Product Submission R2, DSTU Release 2
HL7 V3 RP, DSTU R2-2012

DRAFT STANDARD FOR TRIAL USE – November 2012

Proceed to V3 Content: Version 3 Standard: Regulated Product Submission R2, DSTU Release 2 HTML Content

Publication of this draft standard for trial use and comment has been approved by Health Level Seven, Inc. (HL7) Distribution of this draft standard for comment shall not continue beyond twenty-four (24) months from the date of publication. It is expected that following this twenty-four month period, this draft standard, revised as necessary, will be submitted to the American National Standards Institute for approval as an American National Standard. A public review in accordance with established ANSI procedures is required at the end of the trial use period and before a draft standard for trial use may be submitted to ANSI for approval as an American National Standard. This draft standard is not an accredited American National Standard. Suggestions for revision should be directed at http://www.hl7.org/dstucomments/index.cfm

Please note that this release contains a limited file set and is intended to be used with one of the V3 Core Downloads available on the HL7 V3 Ballot web site. Not all menu options will be available although all the files necessary to use this draft standard are included. If you have any questions please contact the Director of Technical Publications at HL7 HQ. See the readme.txt file distributed with this package for additional information about setting up and browsing this material.

IMPORTANT NOTES:

  1. If you are the individual that downloaded or ordered this HL7 Standard, specification or other work (in each and every instance "Material"), the following describes the permitted uses of the Material.
  2. If you are NOT such individual, you are not authorized to make any use of the Material. To obtain an authorized copy of this Material, please visit http://www.hl7.org/implement/standards/index.cfm.
  3. If you are not an HL7 Organizational Member, the following are your permitted uses of this Material:
    1. Read and Copy License Only. HL7 hereby grants you the right, without charge, to download and copy (for personal use only) this Material for study purposes only. This license grant does not include the right to sublicense or modify the Material, or to implement the Material, either in whole in part, in any product or service.
    Please see http://www.hl7.org/legal/ippolicy.cfm for the full license terms governing the Material.
  4. If you are an HL7 Organizational Member, the following are your permitted uses of this Material.

    1 Implementation License Terms.

    1.1 Definitions. As used in this Agreement, the following terms shall have the following definitions:

    "Compliant Product" is a product or service that implements Material that is an HL7 Specification in whole or in part.

    "End User" is a company, entity or individual that is the ultimate purchaser or licensee from Licensee of a Compliant Product.

    1.2 License. In consideration of becoming an Organizational member of HL7 and continuing to pay the appropriate HL7 Organizational membership fees in full, HL7 hereby grants to you without additional charge, on a perpetual (except as provided for in the full license terms governing the Material), non-exclusive and worldwide basis, the right to (a) download, copy (for internal purposes only) and share this Material with your employees and consultants for study purposes, and (b) utilize the Material for the purpose of developing, making, having made, using, marketing, importing, offering to sell or license, and selling or licensing, and to otherwise distribute, Compliant Products, in all cases subject to the conditions set forth in this Agreement and any relevant patent and other intellectual property rights of third parties (which may include members of HL7). No other license, sublicense, or other rights of any kind are granted under this Agreement.
Please see http://www.hl7.org/legal/ippolicy.cfm for the full license terms governing the Material.